No difference in overall survival was then observed when comparing patients with t(8;21) alone versus patients with additional cytogenetic abnormalities the only possible exception being loss of the Y chromosome that was associated with an improved survival of borderline significance in the MRC study.
← all excerpts
Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.
1
—
—